Research output per year
Research output per year
Fingerprint
Dive into the research topics where Pirkko-Liisa Kellokumpu-Lehtinen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Acute Side-effects of Different Radiotherapy Treatment Schedules in Early Prostate Cancer
Reinikainen, P., Kapanen, M., Luukkaala, T. & Kellokumpu-Lehtinen, P. L., 2022, In: Anticancer research. 42, 5, p. 2553-2565 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial
Joensuu, H., Kellokumpu-Lehtinen, P. L., Huovinen, R., Jukkola, A., Tanner, M., Ahlgren, J., Auvinen, P., Lahdenpera, O., Villman, K., Nyandoto, P., Nilsson, G., Poikonen-Saksela, P., Kataja, V., Bono, P., Junnila, J. & Lindman, H., 2022, In: Journal of Clinical Oncology. 40, 10, p. 1051-1058 8 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile2 Citations (Scopus) -
A graphical LASSO analysis of global quality of life, sub scales of the EORTC QLQ-C30 instrument and depression in early breast cancer
Poikonen-Saksela, P., Kolokotroni, E., Vehmanen, L., Mattson, J., Stamatakos, G., Huovinen, R., Kellokumpu-Lehtinen, P. L., Blomqvist, C. & Saarto, T., Feb 2022, In: Scientific Reports. 12, 2112.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile2 Downloads (Pure) -
A Higher Mean Heart Radiation Dose Induces Higher Frequency of Multiple Cardiac Changes
Tuohinen, S. S., Aula, H., Skyttä, T., Huhtala, H., Keski-Pukkila, K., Nikus, K., Virtanen, V., Kellokumpu-Lehtinen, P. L. & Raatikainen, P., May 2022, In: Anticancer research. 42, 5, p. 2519-2529 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Dynamic Integrated Backscatter Detects Radiotherapy-induced Cardiac Changes Better than Strain Analysis: A Prospective Three-year Study
Tuohinen, S. S., Skytta, T., Huhtala, H., Virtanen, V., Kellokumpu-Lehtinen, P. L. & Raatikainen, P., 2022, In: Anticancer research. 42, 5, p. 2507-2517 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
Activities
-
High baseline Tie1 predicts poor survival in metastatic breast cancer
L Tiainen (Contributor), EA Korhonen (Contributor), T Luukkaala (Contributor), M Hämäläinen (Contributor), M Tanner (Contributor), O Lahdenperä (Contributor), P Vihinen (Contributor), A Jukkola (Contributor), P Karihtala (Contributor), E Moilanen (Contributor), K Alitalo (Contributor) & PL Kellokumpu-Lehtinen (Contributor)
21 Mar 2018Activity: Talk or presentation › Conference presentation
-
Kilpirauhassyövän sairastaneiden potilaiden kardiovaskulaarisairastavuus ja -kuolleisuus
Heini Huhtala (Contributor), Pia Jaatinen (Contributor) & Pirkko-Liisa Kellokumpu-Lehtinen (Contributor)
23 Mar 2017Activity: Talk or presentation › Conference presentation
-
Adjuvant capesitabine in combination with docetaxel (T), epirubicin (E), and cyclophosphamide (C) in the treatment of early breast cancer (BC): 10-year survival results from the randomized FinXX trial
Heikki Joensuu (Keynote speaker), Pirkko-Liisa Kellokumpu-Lehtinen (Keynote speaker), Riikka Huovinen (Keynote speaker), Arja Jukkola-Vuorinen (Keynote speaker), Mina Tanner (Keynote speaker), Riitta Kokko (Keynote speaker), Päivi Auvinen (Keynote speaker), Outi Lahdenperä (Keynote speaker), Kenneth Villman (Keynote speaker), Paul Nyandoto (Keynote speaker), Greger Nilsson (Keynote speaker), Marja Murashev (Keynote speaker), Paula Poikonen-Saksela (Keynote speaker), Petri Bono (Keynote speaker), Vesa Kataja (Keynote speaker) & Henrik Lindman (Keynote speaker)
9 Jul 2016Activity: Talk or presentation › Invited lecture
-
A randomized phase III trial between adjuvant docetaxel and surveillance after radical prostatectomy for high risk prostate cancer : Results of SPCG12
Teuvo Tammela (Speaker) & Pirkko-Liisa Kellokumpu-Lehtinen (Speaker)
7 Jun 2016Activity: Talk or presentation › Conference presentation
-
Hoitoratkaisut elämän loppuvaiheen hoidossa
Pirkko-Liisa Kellokumpu-Lehtinen (Keynote speaker)
16 Mar 2016Activity: Talk or presentation › Invited lecture